Navigation Links
Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Company's Inaccurate Description of Federal Court's Recent Certification Ruling
Date:7/6/2012

NEW YORK, July 6, 2012 /PRNewswire/ -- On MSLGroup's website, the Company claims that U.S. District Court Judge Andrew L. Carter's June 29, 2012 order granting conditional certification to the Company's women VPs and SVPs "was a procedural ruling only and not unexpected" and that the Court had "made no decision as to whether the case may proceed as a class action."  But in a statement issued today, Janette Wipper, a partner at Sanford Wittels & Heisler, LLP, the plaintiffs' lead counsel, strongly contested MSL's characterization of Judge Carter's certification decision. 

"MSLGroup's assertion on its website that the decision was 'expected' and simply 'procedural' differs from its lawyer's statements in Court," said Ms. Wipper. MSLGroup and Publicis Groupe consistently argued in their briefs that plaintiffs could not obtain conditional certification and that it would be 'unprecedented' for Judge Carter to order such relief. The very first line of the papers MSLGroup submitted to the Court on March 19, 2012, claims: 'Plaintiffs ask this Court to make an unprecedented ruling….'   The papers go on to state that 'federal courts have conditionally certified fewer than ten [Equal Pay Act] cases in nearly 50 years….' They certainly conveyed to the Court that ordering certification would be an unexpected result with a significant impact on the lawsuit." "Furthermore," noted Ms. Wipper, "MSLGroup hired an MIT-educated expert in hopes of refuting Plaintiffs' statistical evidence in support of conditional certification."

In his written opinion, Judge Carter decided that plaintiffs had provided "sufficient information that because of a common pay scale, [plaintiffs] were paid lower than the wages paid to men for the performance of substantially equal work."  The Judge relied on the findings of plaintiffs' statistical expert, Dr. Janice Madden, that female VPs and SVPs at Publicis Groupe were paid 8.5% to 11.2% less annually than male VPs and SVPs.  The judge also stated he was ordering notice of conditional certification to be sent to over a hundred of the Company's current and former female Vice Presidents and Senior Vice Presidents, so that they could join the class.

According to Steven Wittels, counsel for the plaintiffs and the class, MSL's erroneous description of Judge Carter's decision is no accident: "MSL is downplaying Judge Carter's extremely important ruling in an attempt to chill participation in the lawsuit from women whose rights to equal pay and equal job treatment have been violated."

The plaintiffs and the class are represented by Janette Wipper, Steven Wittels, Siham Nurhussein, and Deepika Bains of Sanford Wittels & Heisler, LLP.  In 2010, Sanford Wittels & Heisler settled the nation's largest gender discrimination class action, after winning a $253 million verdict from a federal jury in New York.

About Sanford Wittels & Heisler, LLP

Sanford Wittels & Heisler is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, qui tam and consumer actions and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. In May 2010, the firm won the largest jury award in the U.S. in a gender discrimination employment class action when a jury returned a verdict of $253 million in compensatory and punitive damages against Novartis Pharmaceuticals Corporation.  In May 2012, SWH won final court approval to settle a wage and hour case on behalf of pharmaceutical representatives employed by Novartis Pharmaceuticals for $99 million.  For more information, contact Sanford Wittels & Heisler at (415) 795-2020.

For more information, contact Jamie Moss, newsPRos, 201-493-1027, 201-788-0142 (cell); or Jaime Baum, newsPRos, 847-502-3825.

 

 

 


'/>"/>
SOURCE Sanford Wittels & Heisler, LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
2. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
3. Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action In Southern District Of New York
4. Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device
5. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
6. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
7. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
8. eCardios CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.
9. The Female Health Company Reports Second Quarter Operating Results
10. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
11. United Spinal To "Roll on Capitol Hill:" Voices Aim to Impact Federal Health Care Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):